by Usha Govindarajulu | Jan 20, 2021 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
As we continue to hear news of COVID-19 variants making their landfall and presence in the United States, the mass vaccination campaign continues. Meanwhile as cases continue to surge, hospitals are overflowing, and deaths have reached almost 400,000, vaccinations...
by Usha Govindarajulu | Jan 6, 2021 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
In the last several weeks we have been hearing news that a new variant, B.I.I.7, of COVID-19, first detected in the United Kingdom is being detected in other countries as well, including the United States. The onset of this new variant is bad timing since the United...
by Usha Govindarajulu | Dec 23, 2020 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
Recently, the Pfizer© vaccine for COVID-19 has come under scrutiny for components in their vaccine which could lead to severe reactions by recipients of the vaccine and therefore could lead to anaphylaxis. Allergies to these components, especially polyethylene glycol...
by Usha Govindarajulu | Dec 9, 2020 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
As more and more news come out about vaccines against COVID-19, people are starting to have concern and worry. Naturally, they are asking a lot of questions about receiving the vaccine and when. Most of the news has centered around two vaccines that have already been...
by Usha Govindarajulu | Nov 25, 2020 | Biostatistics, Blog, Epidemiology, New York, Professor, Usha Govindarajulu
After most of the United States was enjoying somewhat of a break in COVID-19 surges and closures in the latter part of the summer, COVID-19, which still roams freely, has led into a second resurgence in almost every state in the latter fall and is leading to potential...
by Usha Govindarajulu | Sep 29, 2020 | Epidemiology, Healtcare, Professor
What makes someone have lasting immunity to COVID-19? This is a burning question in order to understand how to protect against the virus and sustain immunity. This also has implications for the various vaccines that are either in development or in testing phases. ...
